Annual FCF
-$67.70 M
+$56.75 M+45.60%
December 1, 2024
Summary
- As of March 13, 2025, ALVR annual free cash flow is -$67.70 million, with the most recent change of +$56.75 million (+45.60%) on December 1, 2024.
- During the last 3 years, ALVR annual FCF has risen by +$38.64 million (+36.33%).
- ALVR annual FCF is now -3584.56% below its all-time high of $1.94 million, reached on December 31, 2018.
Performance
ALVR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$3.57 M
+$4.87 M+57.73%
December 1, 2024
Summary
- As of March 13, 2025, ALVR quarterly free cash flow is -$3.57 million, with the most recent change of +$4.87 million (+57.73%) on December 1, 2024.
- Over the past year, ALVR quarterly FCF has increased by +$4.87 million (+57.73%).
- ALVR quarterly FCF is now -80.42% below its all-time high of -$1.98 million, reached on March 31, 2019.
Performance
ALVR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$67.70 M
+$27.17 M+28.64%
December 1, 2024
Summary
- As of March 13, 2025, ALVR TTM free cash flow is -$67.70 million, with the most recent change of +$27.17 million (+28.64%) on December 1, 2024.
- Over the past year, ALVR TTM FCF has increased by +$27.17 million (+28.64%).
- ALVR TTM FCF is now -3324.63% below its all-time high of -$1.98 million, reached on March 31, 2019.
Performance
ALVR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALVR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.6% | +57.7% | +28.6% |
| 3 y3 years | +36.3% | +57.7% | +28.6% |
| 5 y5 years | -230.4% | +57.7% | +28.6% |
ALVR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.3% | at high | +92.3% | at high | +52.3% |
| 5 y | 5-year | -230.4% | +52.3% | at high | +92.3% | -230.4% | +52.3% |
| alltime | all time | -3584.6% | +52.3% | -80.4% | +92.3% | -3324.6% | +52.3% |
AlloVir Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$67.70 M(-45.6%) | -$3.57 M(-57.7%) | -$67.70 M(-28.6%) |
| Sep 2024 | - | -$8.44 M(-25.4%) | -$94.87 M(-21.5%) |
| Jun 2024 | - | -$11.32 M(-74.5%) | -$120.91 M(-11.6%) |
| Mar 2024 | - | -$44.38 M(+44.4%) | -$136.71 M(+9.9%) |
| Dec 2023 | -$124.45 M(-12.4%) | -$30.73 M(-10.9%) | -$124.45 M(-0.7%) |
| Sep 2023 | - | -$34.48 M(+27.1%) | -$125.29 M(-0.5%) |
| Jun 2023 | - | -$27.12 M(-15.6%) | -$125.94 M(-1.4%) |
| Mar 2023 | - | -$32.12 M(+1.7%) | -$127.69 M(-10.1%) |
| Dec 2022 | -$142.05 M(+33.6%) | -$31.57 M(-10.1%) | -$142.05 M(+2.8%) |
| Sep 2022 | - | -$35.13 M(+21.6%) | -$138.18 M(-1.0%) |
| Jun 2022 | - | -$28.88 M(-37.9%) | -$139.52 M(+4.3%) |
| Mar 2022 | - | -$46.48 M(+67.8%) | -$133.82 M(+25.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$106.34 M(+74.2%) | -$27.70 M(-24.1%) | -$106.34 M(+6.6%) |
| Sep 2021 | - | -$36.47 M(+57.4%) | -$99.74 M(+22.6%) |
| Jun 2021 | - | -$23.18 M(+22.0%) | -$81.33 M(+17.4%) |
| Mar 2021 | - | -$19.00 M(-9.9%) | -$69.27 M(+13.9%) |
| Dec 2020 | -$61.05 M(+197.9%) | -$21.09 M(+16.8%) | -$60.81 M(+24.9%) |
| Sep 2020 | - | -$18.06 M(+62.4%) | -$48.71 M(+31.5%) |
| Jun 2020 | - | -$11.12 M(+5.5%) | -$37.05 M(+27.5%) |
| Mar 2020 | - | -$10.54 M(+17.3%) | -$29.06 M(+41.8%) |
| Dec 2019 | -$20.49 M(-1154.8%) | -$8.99 M(+40.5%) | -$20.49 M(+78.1%) |
| Sep 2019 | - | -$6.40 M(+104.2%) | -$11.51 M(+125.2%) |
| Jun 2019 | - | -$3.13 M(+58.4%) | -$5.11 M(+158.4%) |
| Mar 2019 | - | -$1.98 M | -$1.98 M |
| Dec 2018 | $1.94 M | - | - |
FAQ
- What is AlloVir annual free cash flow?
- What is the all time high annual FCF for AlloVir?
- What is AlloVir annual FCF year-on-year change?
- What is AlloVir quarterly free cash flow?
- What is the all time high quarterly FCF for AlloVir?
- What is AlloVir quarterly FCF year-on-year change?
- What is AlloVir TTM free cash flow?
- What is the all time high TTM FCF for AlloVir?
- What is AlloVir TTM FCF year-on-year change?
What is AlloVir annual free cash flow?
The current annual FCF of ALVR is -$67.70 M
What is the all time high annual FCF for AlloVir?
AlloVir all-time high annual free cash flow is $1.94 M
What is AlloVir annual FCF year-on-year change?
Over the past year, ALVR annual free cash flow has changed by +$56.75 M (+45.60%)
What is AlloVir quarterly free cash flow?
The current quarterly FCF of ALVR is -$3.57 M
What is the all time high quarterly FCF for AlloVir?
AlloVir all-time high quarterly free cash flow is -$1.98 M
What is AlloVir quarterly FCF year-on-year change?
Over the past year, ALVR quarterly free cash flow has changed by +$4.87 M (+57.73%)
What is AlloVir TTM free cash flow?
The current TTM FCF of ALVR is -$67.70 M
What is the all time high TTM FCF for AlloVir?
AlloVir all-time high TTM free cash flow is -$1.98 M
What is AlloVir TTM FCF year-on-year change?
Over the past year, ALVR TTM free cash flow has changed by +$27.17 M (+28.64%)